HUP0301129A2 - Novel compounds - Google Patents

Novel compounds

Info

Publication number
HUP0301129A2
HUP0301129A2 HU0301129A HUP0301129A HUP0301129A2 HU P0301129 A2 HUP0301129 A2 HU P0301129A2 HU 0301129 A HU0301129 A HU 0301129A HU P0301129 A HUP0301129 A HU P0301129A HU P0301129 A2 HUP0301129 A2 HU P0301129A2
Authority
HU
Hungary
Prior art keywords
novel compounds
polypeptides
polynucleotides
compounds
apolypeptides
Prior art date
Application number
HU0301129A
Other languages
Hungarian (hu)
Inventor
Pankaj Agarwal
John P. Cogswell
Karen S. Kabnic
Ying-Ta Lai
Shelby A. Martensen
Paul R. Murdock
Safia K. Rizni
Randall F. Smith
Jay C. Strum
Zhaoying Xiang
Qing Xie
Original Assignee
Glaxo Group Ltd.
Smithkline Beecham Corp.
Smithkline Beecham Plc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd., Smithkline Beecham Corp., Smithkline Beecham Plc. filed Critical Glaxo Group Ltd.
Publication of HUP0301129A2 publication Critical patent/HUP0301129A2/en
Publication of HUP0301129A3 publication Critical patent/HUP0301129A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

A találmány újonnan azonosított polipeptidekre és az ezeket apolipeptideket kódoló polinukleotidokra vonatkozik. A találmány tárgyatovábbá ezek diagnosztikai alkalmazása és olyan vegyületekazonosításában történő alkalmazása, melyek agonisták vagy antagonistáklehetnek, és potenciálisan terápiásan felhasználhatóak. A találmánytárgya ezeknek a polipeptideknek és polinukleotidoknak az előállításieljárása is. ÓThe invention relates to newly identified polypeptides and the polynucleotides encoding these apolypeptides. The invention further discusses their diagnostic use and their use in the identification of compounds that can be agonists or antagonists and can potentially be used therapeutically. The subject of the invention is also the production method of these polypeptides and polynucleotides. HE

HU0301129A 2000-06-22 2001-06-22 Novel compounds HUP0301129A3 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US21316100P 2000-06-22 2000-06-22
US21315600P 2000-06-22 2000-06-22
PCT/US2001/019929 WO2001098342A1 (en) 2000-06-22 2001-06-22 Novel compounds

Publications (2)

Publication Number Publication Date
HUP0301129A2 true HUP0301129A2 (en) 2003-08-28
HUP0301129A3 HUP0301129A3 (en) 2005-12-28

Family

ID=26907817

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0301129A HUP0301129A3 (en) 2000-06-22 2001-06-22 Novel compounds

Country Status (15)

Country Link
EP (1) EP1292617A4 (en)
JP (1) JP2004500869A (en)
KR (1) KR20030021178A (en)
CN (1) CN1444599A (en)
AU (1) AU2001268671A1 (en)
BR (1) BR0111877A (en)
CA (1) CA2414005A1 (en)
CZ (1) CZ20024148A3 (en)
HU (1) HUP0301129A3 (en)
IL (1) IL153568A (en)
MX (1) MXPA03000227A (en)
NO (1) NO20026162L (en)
NZ (1) NZ523122A (en)
PL (1) PL359937A1 (en)
WO (1) WO2001098342A1 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6558936B1 (en) * 1999-10-01 2003-05-06 Millennium Pharmaceuticals, Inc. Human lipase proteins, nucleic acids encoding them, and uses of both of these
EP1234035B1 (en) * 1999-12-03 2010-02-24 ZymoGenetics, Inc. Human cytokine receptor
US20030170823A1 (en) 1999-12-23 2003-09-11 Presnell Scott R. Novel cytokine ZCYTO18
ATE547525T1 (en) 2000-08-08 2012-03-15 Zymogenetics Inc SOLUBLE ZCYCTOR 11 CYTOKINE RECEPTORS
AU2002227352A1 (en) * 2000-10-20 2002-04-29 Incyte Genomics, Inc. Human kinases
JP2004535154A (en) * 2000-11-15 2004-11-25 レキシコン・ジェネティクス・インコーポレーテッド Novel human secretory protein and polynucleotide encoding the same
US6903201B2 (en) 2001-01-05 2005-06-07 Curagen Corporation Proteins and nucleic acids encoding same
JP2005509400A (en) * 2001-01-05 2005-04-14 キュラジェン コーポレイション Protein and nucleic acid encoding it
MXPA03006218A (en) * 2001-01-12 2004-09-13 Inst Genetics Llc Type 2 ctokine receptor and nucleic acids encoding same.
US20030099608A1 (en) 2001-03-27 2003-05-29 Presnell Scott R. Human cytokine receptor
US6867030B2 (en) * 2001-03-29 2005-03-15 Applera Corporation Isolated human lipase proteins, nucleic acid molecules encoding human lipase proteins, and uses thereof
WO2003072767A2 (en) * 2002-02-27 2003-09-04 Bayer Healthcare Ag Regulation of human lipase
US7265211B2 (en) 2002-03-22 2007-09-04 Zymogenetics, Inc. Anti-IL-TIF antibodies and methods of making
EP1606316A2 (en) 2003-03-24 2005-12-21 ZymoGenetics, Inc. Anti-il-20 antibodies and binding partners and methods of using in inflammation
WO2006047249A1 (en) 2004-10-22 2006-05-04 Zymogenetics, Inc. Anti-il-22ra antibodies and binding partners and methods of using in inflammation
AU2006342792A1 (en) 2005-12-02 2007-11-08 Genentech, Inc. Compositions and methods for the treatment of diseases and disorders associated with cytokine signaling involving antibodies that bind to IL-22 and IL-22R

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5457038A (en) * 1988-11-10 1995-10-10 Genetics Institute, Inc. Natural killer stimulatory factor
JP2879303B2 (en) * 1993-01-14 1999-04-05 佑 本庶 Method for preparing cDNA library, novel polypeptide and DNA encoding the same
US5536637A (en) * 1993-04-07 1996-07-16 Genetics Institute, Inc. Method of screening for cDNA encoding novel secreted mammalian proteins in yeast
US5707829A (en) * 1995-08-11 1998-01-13 Genetics Institute, Inc. DNA sequences and secreted proteins encoded thereby
US6558936B1 (en) * 1999-10-01 2003-05-06 Millennium Pharmaceuticals, Inc. Human lipase proteins, nucleic acids encoding them, and uses of both of these
PL358580A1 (en) * 2000-04-27 2004-08-09 Smithkline Beecham Corporation Novel compounds

Also Published As

Publication number Publication date
HUP0301129A3 (en) 2005-12-28
EP1292617A1 (en) 2003-03-19
CA2414005A1 (en) 2001-12-27
IL153568A (en) 2003-10-31
EP1292617A4 (en) 2005-04-06
AU2001268671A1 (en) 2002-01-02
NO20026162L (en) 2003-02-21
NZ523122A (en) 2004-06-25
KR20030021178A (en) 2003-03-12
IL153568A0 (en) 2003-07-06
PL359937A1 (en) 2004-09-06
CN1444599A (en) 2003-09-24
WO2001098342A1 (en) 2001-12-27
CZ20024148A3 (en) 2003-05-14
MXPA03000227A (en) 2004-05-21
JP2004500869A (en) 2004-01-15
NO20026162D0 (en) 2002-12-20
BR0111877A (en) 2003-06-24

Similar Documents

Publication Publication Date Title
HUP0301129A2 (en) Novel compounds
HUP0300595A2 (en) Novel compounds
HUP0303143A2 (en) Combined use of factor vii polypeptides and factor ix polypeptides
HUP0203064A2 (en) Granules based on starch and lactose
HUP0300299A2 (en) Composition comprising free amino acids
ATE360077T1 (en) 22025, A NEW HUMAN CYCLIC NUCLEOTIDE PHOSPHODIESTERASE
HUP0400648A2 (en) Compositions for antitumour treatment containing ecteinascidin 743
HUP0300701A2 (en) Zolpidem hemitartrate, process for its preparation and pharmaceutical compositions containing it
WO2005019264A3 (en) Human lxr alpha variants
GB0006289D0 (en) New use
WO2002002630A3 (en) Hcn polypeptides and polynucleotides and their use in therapy
WO2003018798A3 (en) G-protein coupled receptor and dna sequences thereof
WO2003048323A3 (en) Polynucleotides and polypeptides associated with the development of rheumatoid arthritis
HUP0104408A2 (en) Mammaglobin, a secreted mammary-specific breast cancer protein
HUP0200475A2 (en) Perfluoroalkylamide, the production thereof and the use thereof in diagnostics
ATE339447T1 (en) HIGH-AFFFINE ANTAGONISTS OF THE ELR-CXC CHEMOKINES
TR200402030T4 (en) Substituted I-aminobutan-3-ol-derivatives
HUP0303154A2 (en) New crystal forms of oxcarbazepine and processes for their preparation
ATE373718T1 (en) 17867, A HUMAN AMINOOPEPTIDASE
ATE364697T1 (en) EDG8 RECEPTOR, ITS PRODUCTION AND USE
HUP0304050A2 (en) Modified fvii in treatment of ards
WO2001036605A3 (en) 2786, a human aminopeptidase
WO2003018066A3 (en) A murine genomic polynucleotide sequence encoding a g-protein coupled receptor and methods of use therefor
WO2001023590A3 (en) 22196, a novel human aminopeptidase
WO2001064880A3 (en) Human dynamin 40322

Legal Events

Date Code Title Description
FA9A Lapse of provisional patent protection due to relinquishment or protection considered relinquished